Micromedex NeoFax Reference

Veröffentlicht von: Merative

Beschreibung

Micromedex NeoFax Reference app is free to subscribers of Merative Micromedex NeoFax Ref online.
Micromedex NeoFax Reference allows clinicians to make accurate and more informed treatment decisions at the point of care, while minimizing errors in this vulnerable patient population. This neonatal-specific app has clinical value for doctors, nurses, and pharmacists. An internet connection is not required, allowing you to make decisions with confidence at anytime, from anywhere.
Micromedex NeoFax Reference app is a trusted source for neonatal drug dosing, based on the strict editorial policies and practices that have guided Merative Micromedex for almost 40 years. Evidence-based, fully referenced neonatal-specific drug information enables clinicians to make informed treatment decisions. The drug monographs cover information including: dose, administration, uses, contraindications/precautions, adverse effects, monitoring, pharmacology, special considerations/preparation, solution- and drug-drug compatibility/incompatibility information, and references. This mobile app also includes a comprehensive enteral formulas component providing nutritional information for approximately 60 different neonatal and infant formulas, and human milk fortifiers.
Micromedex NeoFax Reference drug information is intended for full-term babies up to 28 days of age (PNA) and preterm babies up to 44 weeks postmenstrual age (GA + PNA).
Do you work at a facility that subscribes to Merative Micromedex® NeoFax®? Check with your Head of Pediatrics, Director of Pediatrics, Director of the NICU, Director of Pharmacy, Medical Librarian, or anyone else at your facility responsible for clinical reference information.
If you work at a facility that subscribes to Merative Micromedex® NeoFax® you may obtain free access to this app with your Micromedex NeoFax Reference password. Contact support at https://merative.my.site.com/mysupport/s/micromedex-support-request
Ausblenden Mehr anzeigen...

Screenshots

Micromedex NeoFax Reference Häufige Fragen

  • Ist Micromedex NeoFax Reference kostenlos?

    Ja, Micromedex NeoFax Reference ist komplett kostenlos und enthält keine In-App-Käufe oder Abonnements.

  • Ist Micromedex NeoFax Reference seriös?

    Nicht genügend Bewertungen, um eine zuverlässige Einschätzung vorzunehmen. Die App benötigt mehr Nutzerfeedback.

    Danke für die Stimme

  • Wie viel kostet Micromedex NeoFax Reference?

    Micromedex NeoFax Reference ist kostenlos.

  • Wie hoch ist der Umsatz von Micromedex NeoFax Reference?

    Um geschätzte Einnahmen der Micromedex NeoFax Reference-App und weitere AppStore-Einblicke zu erhalten, können Sie sich bei der AppTail Mobile Analytics Platform anmelden.

Benutzerbewertung
Die App ist in Polen noch nicht bewertet.
Bewertungsverlauf

Micromedex NeoFax Reference Bewertungen

Can’t log in this app

Polmu on

Thailand

It showed “unable to download content, please check your device” How can i fix this problem ??

Store-Rankings

Ranking-Verlauf
App-Ranking-Verlauf noch nicht verfügbar
Kategorien-Rankings
Diagramm
Kategorie
Rang
Top Kostenlos
56
Top Kostenlos
112
Top Kostenlos
128
Top Kostenlos
163
Top Kostenlos
188

Micromedex NeoFax Reference Konkurrenten

Name
Sanford Guide
Infectious Diseases Treatment
NCCN Guidelines®
Clinical Guidelines
Pediatric OnCall
www.pediatriconcall.com
UpToDate Lexidrug
IDSA Practice Guidelines
Ped(z) - Pediatric Calculator
Thai CV Risk Calculator
Cardiovascular Risk Assessment
Harriet Lane Handbook
Pediatric Formulary & PubMed
BiliBuddy
Medical Calculators Pediatrics
Pediatric Oncall

Micromedex NeoFax Reference Installationen

Letzte 30 Tage

Micromedex NeoFax Reference Umsatz

Letzte 30 Tage

Micromedex NeoFax Reference Einnahmen und Downloads

Gewinnen Sie wertvolle Einblicke in die Leistung von Micromedex NeoFax Reference mit unserer Analytik.
Melden Sie sich jetzt an, um Zugriff auf Downloads, Einnahmen und mehr zu erhalten.
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.